The impact of the Canadian Hypertension Education Program on antihypertensive prescribing trends

Hypertension

Volumn 47, Issue 1, 2006, Pages 22-28

  Campbell, Norman R C ^a   Tu, Karen ^b,c,d   Brant, Rollin ^e   Minh, Duong Hua ^b   McAlister, Finlay A ^f,g  

^a UNIVERSITY OF CALGARY   (Canada)

^b INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^c UNIVERSITY HEALTH NETWORK   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^f UNIVERSITY OF ALBERTA   (Canada)

^g UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Drug therapy; Hypertension; Prospective studies

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; THIAZIDE DIURETIC AGENT;

AGED; ARTICLE; CANADA; CLINICAL TRIAL; COHORT ANALYSIS; CORRELATION ANALYSIS; DATA BASE; DIABETES MELLITUS; HEALTH PROGRAM; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MEDICAL EDUCATION; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; STATISTICS; TIME SERIES ANALYSIS;

AGED; ANTIHYPERTENSIVE AGENTS; CANADA; EDUCATION, MEDICAL, CONTINUING; EVIDENCE-BASED MEDICINE; HUMANS; HYPERTENSION; ONTARIO; PRESCRIPTIONS, DRUG;

EID: 31744447260     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000196269.98463.fd     Document Type: Article

References (22)

1. World Health Organization. The World Health Report 2002. Geneva, Switzerland: World Health Organization; 2002.
2. Wolf-Maier K, Cooper RS, Banegas JR, Giampaoli S, Hense HW, Joffres M, Kastarinen M, Poulter P, Rodriguez-Artalejo F, Stegmayr B, Thamm M, Tuomilehto J, Vanuzzo D, Vescio F. Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA. 2003;289:2363-2369.
3. Primatesta P, Brookes M, Poulter NR. Improved hypertension management and control. Results from the Health Survey for England 1998. Hypertension. 2001;38:827-832.
4. Joffres MR, Hamet P, MacLean DR, L'Italien GJ, Fodor G. Distribution of blood pressure and hypertension in Canada and the United States. Am J Hypertens. 2001;14:1099-1105.
5. Zarnke KB, Campbell NRC, McAlister FA, Levine M. A novel process for updating recommendations for managing hypertension: Rationale and methods. Can J Cardiol. 2000;16:1094-1102.
6. Campbell NRC, Nagpal S, Drouin D. Implementing hypertension recommendations. Can J Cardiol. 2001;17:851-853.
7. Campbell NRC, McAlister FA, Brant R, Levine M, Drouin D, Feldman R, Herman R, Zarnke K. Temporal trends in antihypertensive drug prescriptions in Canada before and after introduction of the Canadian Hypertension Education Program. J Hypertens. 2003;21:1591-1597.
8. Tu K, Campbell NRC, Duong-Hua M, McAlister FA. Hypertension management in the elderly has improved: Ontario prescribing trends, 1994-2002. Hypertension. 2005;45:1113-1118.
9. Feldman RD, Campbell N, Larochelle P, Bolli P, Burgess ED, Carruthers SG, Floras JS, Haynes RB, Honos G, Leenen FHH, Leiter LA, Logan AG, Myers MG, Spence JD, Zarnke KB. 1999 Canadian recommendations for the management of hypertension. CMAJ. 1999;161:S1-S17.
10. McAlister FA, Levine M, Zarnke KB, Campbell N, Lewanczuk R, Leenen F, Rabkin S, Wright JM, Stone J, Feldman RD, Lebel M, Honos G, Fodor G, Burgess E, Tobe S, Hamet P, Herman R, Irvine J, Culleton B, Petrella R, Touyz R, for the Canadian Hypertension Recommendations Working Group. The 2000 Canadian recommendations for the management of hypertension: Part one - therapy. Can J Cardiol. 2001;17:543-559.
11. Campbell NR, Onysko J, Maxwell C, Eliasziw M, Zhang JX. Increases in the diagnosis and drug treatment of hypertensive Canadians. Can J Cardiol. 2005;21(Suppl C):67C Abstract.
12. Siegel D, Lopez J. Trends in antihypertensive drug use in the United States. Do the JNC V recommendations affect prescribing? JAMA. 1997;278:1745-1748.
13. Beaulieu M-D, Dufresne L, LeBlanc D. Treating hypertension. Are the right drugs given to the right patients? Can Fam Physician. 1998;44:294-302.
14. Hyman DJ, Pavlik VN. Self-reported hypertension treatment practices among primary care physicians. Arch Intern Med. 2000;160:2281-2286.
15. Tu K, Mamdani MM, Tu JV. Hypertension guidelines in elderly patients: Is anybody listening? Am J Med. 2002;113:52-58.
16. Milchak JL, Carter BL, James PA, Ardery G. Measuring adherence to practice guidelines for the management of hypertension. An evaluation of the literature. Hypertension. 2004;44:602-608.
17. McAlister FA, Padwal R. Implementation of guidelines for diagnosing and treating hypertension. Dis Manage Health Outcomes. 2001;9:361-369.
18. Grimshaw JM, Shirran L, Thomas R, Mowat G, Fraser C, Bero L, Grilli R, Harvey E, Oxman A, O'Brien MA Changing provider behavior: an overview of systematic reviews of interventions. Med Care. 2001;39(suppl 2):II-2-II-45.
19. Majumdar SR, McAlister FA, Furberg CD. From publication to practice in chronic cardiovascular disease: The long and winding road. J Am Coll Cardiol. 2004;43:1738-1742.
20. Blood Pressure Lowering Treatment Trialists' Collaboration. Effects of ACE inhibitors, calcium antagonists, and other blood pressure lowering drugs: results of prospectively designed overviews of randomised trials. Lancet. 2000;356:1955-1964.
21. Wang TJ, Ausiello JC, Stafford RS. Trends in antihypertensive drug advertising, 1985-1996. Circulation. 1999;99:2055-2057.
22. Lenfant C. Reflections on hypertension control rates. Arch Intern Med. 2002;162:131-132.